JP2022500418A5 - - Google Patents

Info

Publication number
JP2022500418A5
JP2022500418A5 JP2021513958A JP2021513958A JP2022500418A5 JP 2022500418 A5 JP2022500418 A5 JP 2022500418A5 JP 2021513958 A JP2021513958 A JP 2021513958A JP 2021513958 A JP2021513958 A JP 2021513958A JP 2022500418 A5 JP2022500418 A5 JP 2022500418A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
phenyl
deuteroalkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021513958A
Other languages
English (en)
Japanese (ja)
Other versions
JP7599411B2 (ja
JP2022500418A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/050719 external-priority patent/WO2020056072A1/en
Publication of JP2022500418A publication Critical patent/JP2022500418A/ja
Publication of JP2022500418A5 publication Critical patent/JP2022500418A5/ja
Application granted granted Critical
Publication of JP7599411B2 publication Critical patent/JP7599411B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021513958A 2018-09-13 2019-09-12 受容体相互作用タンパク質キナーゼ1阻害剤(ripk1)としての1h-インダゾールカルボキサミド Active JP7599411B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862730602P 2018-09-13 2018-09-13
US62/730,602 2018-09-13
PCT/US2019/050719 WO2020056072A1 (en) 2018-09-13 2019-09-12 1h-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (ripk1)

Publications (3)

Publication Number Publication Date
JP2022500418A JP2022500418A (ja) 2022-01-04
JP2022500418A5 true JP2022500418A5 (cg-RX-API-DMAC7.html) 2022-09-05
JP7599411B2 JP7599411B2 (ja) 2024-12-13

Family

ID=68073171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021513958A Active JP7599411B2 (ja) 2018-09-13 2019-09-12 受容体相互作用タンパク質キナーゼ1阻害剤(ripk1)としての1h-インダゾールカルボキサミド

Country Status (14)

Country Link
US (1) US12172975B2 (cg-RX-API-DMAC7.html)
EP (1) EP3849968B1 (cg-RX-API-DMAC7.html)
JP (1) JP7599411B2 (cg-RX-API-DMAC7.html)
KR (1) KR102906523B1 (cg-RX-API-DMAC7.html)
CN (1) CN112673000B (cg-RX-API-DMAC7.html)
AU (1) AU2019337612A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021004385A2 (cg-RX-API-DMAC7.html)
CA (1) CA3112735A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190718A1 (cg-RX-API-DMAC7.html)
ES (1) ES2936481T3 (cg-RX-API-DMAC7.html)
IL (1) IL281370A (cg-RX-API-DMAC7.html)
MX (1) MX2021002509A (cg-RX-API-DMAC7.html)
SG (1) SG11202102405YA (cg-RX-API-DMAC7.html)
WO (1) WO2020056072A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111566103B (zh) 2017-10-30 2023-06-23 百时美施贵宝公司 作为激酶抑制剂的氨基咪唑并吡嗪
US11618753B2 (en) 2018-01-26 2023-04-04 Bristol-Myers Squibb Company Aminopyrrolotriazines as kinase inhibitors
KR102793119B1 (ko) 2018-09-13 2025-04-07 브리스톨-마이어스 스큅 컴퍼니 키나제 억제제로서의 인다졸 카르복스아미드
US12275721B2 (en) 2019-10-03 2025-04-15 Bristol-Myers Squibb Company Indazole carboxamides as kinase inhibitors
US11744824B2 (en) * 2020-09-15 2023-09-05 1ST Biotherapeutics, Inc. 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds
AR123793A1 (es) 2020-10-19 2023-01-11 Bristol Myers Squibb Co Compuestos de triazolopiridinilo como inhibidores de quinasas
WO2025106362A1 (en) * 2023-11-16 2025-05-22 Merck Sharp & Dohme Llc Ripk1 inhibitors and methods of use

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7872014B2 (en) 2003-07-23 2011-01-18 Exelixis, Inc. Anaplastic lymphoma kinase modulators and methods of use
JP2008525464A (ja) 2004-12-22 2008-07-17 メモリー・ファーマシューティカルズ・コーポレイション α−7ニコチン性受容体リガンド並びにその製造及び使用
NZ573735A (en) 2006-05-19 2011-10-28 Abbott Lab Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
KR101061599B1 (ko) 2008-12-05 2011-09-02 한국과학기술연구원 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
WO2010068287A2 (en) 2008-12-11 2010-06-17 Angion Biomedica Corp. Small molecule modulators of hepatocyte growth factor (scatter factor) activity
ES2458872T3 (es) 2009-04-30 2014-05-07 Novartis Ag Derivados de imidazol y su uso como moduladores de quinasas dependientes de ciclina
US8455516B2 (en) 2010-01-15 2013-06-04 Touro University HIV-1 fusion inhibitors and methods
KR20130077390A (ko) * 2011-12-29 2013-07-09 제이더블유중외제약 주식회사 단백질 키나아제 저해활성을 가지는 6-아미노-3-카복스아미도인다졸 유도체
EA024939B1 (ru) 2012-02-21 2016-11-30 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. 1h-индазол-3-карбоксамидные соединения в качестве ингибиторов гликогенсинтазы киназы 3-бета
WO2013124169A1 (en) 2012-02-21 2013-08-29 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
US9783573B2 (en) 2012-09-18 2017-10-10 Bristol-Myers Squibb Company IAP antagonists
CN104781251B (zh) * 2012-11-08 2016-12-14 百时美施贵宝公司 可作为激酶调节剂的经双环杂环取代的吡啶基化合物
BR112016021626A2 (pt) 2014-03-20 2018-05-15 Samumed, Llc indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas
US10933068B2 (en) 2016-05-26 2021-03-02 Sonic Master Limited Modulators of DUX4 for regulation of muscle function
LT3580220T (lt) 2017-02-13 2021-12-27 Bristol-Myers Squibb Company Aminotriazolopiridinai, kaip kinazės inhibitoriai
CN111566103B (zh) 2017-10-30 2023-06-23 百时美施贵宝公司 作为激酶抑制剂的氨基咪唑并吡嗪
US11618753B2 (en) 2018-01-26 2023-04-04 Bristol-Myers Squibb Company Aminopyrrolotriazines as kinase inhibitors
KR102793119B1 (ko) 2018-09-13 2025-04-07 브리스톨-마이어스 스큅 컴퍼니 키나제 억제제로서의 인다졸 카르복스아미드
US12275721B2 (en) 2019-10-03 2025-04-15 Bristol-Myers Squibb Company Indazole carboxamides as kinase inhibitors

Similar Documents

Publication Publication Date Title
AU2017283769B2 (en) Compounds and compositions for inhibiting the activity of SHP2
JP2017511815A5 (cg-RX-API-DMAC7.html)
JP6196156B2 (ja) 過剰増殖性障害および血管新生に関連する疾患の治療のために有用なアミノアルコール置換2,3−ジヒドロイミダゾ[1,2−c]キナゾリン誘導体
ES2660831T3 (es) Derivados de imidazol condensados útiles como inhibidores de IDO
JP2019512505A5 (cg-RX-API-DMAC7.html)
RU2376292C2 (ru) Гамк-ергические модуляторы
JP2022501334A5 (cg-RX-API-DMAC7.html)
ES2639402T3 (es) 2,3-dihidroimidazo[1,2-c]quinolinas sustituidas con arilaminoalcohol
WO2019101642A1 (en) Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides
RU2012117398A (ru) Бензоксазепиновые ингибиторы pi3 и способы применения
RU2012156940A (ru) Лекарственные средства, индуцирующие апоптоз, для лечения рака и иммунных и аутоиммунных заболеваний
RU2010110036A (ru) Производные пиперидина в качестве агонистов мускариновых рецепторов
RU2014115476A (ru) Производные пиразоло[4, 3-с]птридина в качестве ингибиторов киназ
RU2015106434A (ru) Производные типа азаиндазола или диазаиндазола для лечения боли
JP2008526999A5 (cg-RX-API-DMAC7.html)
CN107108554B (zh) 作为midh1抑制剂用于治疗肿瘤的1-环己基-2-苯基氨基苯并咪唑
EA037517B1 (ru) Антипролиферативные соединения и их фармацевтические композиции и применения
RU2012130929A (ru) Гетероциклические соединения в качестве ингибиторов янус-киназы
RU2010136721A (ru) Агонисты мускариновых рецепторов, композиции, способы лечения ими и способы их изготовления
CN107108522A (zh) 作为mIDH1抑制剂的苯并咪唑‑2‑胺
JP2020520957A5 (cg-RX-API-DMAC7.html)
BR112017013148A2 (pt) pirazolopiridinaminas como inibidores mknk1 e mknk2
RU2008125040A (ru) ПРОИЗВОДНЫЕ АРИЛ-ИЗОКСАЗОЛ-4-ИЛ-ИМИДАЗО[1.5-a]ПИРИДИНА
JP2024533787A5 (cg-RX-API-DMAC7.html)
JP2013542237A (ja) アルコキシ−置換2,3−ジヒドロイミダゾ[1,2−c]キナゾリン